MBX (MBX Biosciences) Current Accrued Expense : $3.22 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is MBX Biosciences Current Accrued Expense?

MBX Biosciences's Current Accrued Expense for the quarter that ended in Dec. 2024 was $3.22 Mil.

MBX Biosciences's quarterly Current Accrued Expense increased from Jun. 2024 ($3.69 Mil) to Sep. 2024 ($3.90 Mil) but then declined from Sep. 2024 ($3.90 Mil) to Dec. 2024 ($3.22 Mil).

MBX Biosciences's annual Current Accrued Expense declined from Dec. 2022 ($1.19 Mil) to Dec. 2023 ($1.02 Mil) but then increased from Dec. 2023 ($1.02 Mil) to Dec. 2024 ($3.22 Mil).

MBX Biosciences Current Accrued Expense Historical Data

The historical data trend for MBX Biosciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MBX Biosciences Current Accrued Expense Chart

MBX Biosciences Annual Data

Trend

Dec22

Dec23

Dec24

Current Accrued Expense

1.19

1.02

3.22

MBX Biosciences Quarterly Data
	Dec22	Sep23	Dec23	Jun24	Sep24	Dec24
Current Accrued Expense	Get a 7-Day Free Trial			-	1.02	3.69	3.90	3.22

MBX Biosciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

MBX Biosciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of MBX Biosciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MBX Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MBX Biosciences Inc (NAS:MBX) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

11711 N. Meridian Street, Suite 300, Carmel, IN, USA, 46032

Website

https://www.mbxbio.com

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.